Notable Guests
TL
Ted Love
3x
SO
Sabah Oney
2x
AC
Abe Ceesay
2x
JM
John Maraganore
2x
OS
Otello Stampacchia
2x
VA
Vineeta Agarwala
2x
GS
George Scangos
2x
DS
David Schenkein
2x
JB
Jay Bradner
2x
JL
Jeremy Levin
2x
KS
Ken Song
2x
RR
Ron Renaud
2x
AB
Alexis Borisy
2x
AM
Ankit Mahadevia
1x
AS
Andy Scharenberg
1x
Recent Episodes
✨
Ardem Patapoutian discusses his Nobel Prize-winning research on touch and pain receptors.
✨
Cameron Turtle discusses developing long-lasting antibodies for immune disorders.
✨
Mathai Mammen explores developing alpha helical peptide molecules.
Mathai Mammen
✨
Gary Nabel discusses ModeX Therapeutics' Epstein-Barr Virus vaccine.
Gary Nabel
✨
Jason Coloma discusses genetic medicines for kidney diseases.
Jason Coloma
✨
Lyn Baranowski talks about inhalable medicines for lung diseases.
Lyn Baranowski
✨
Heather Turner discusses a new schizophrenia drug.
Heather Turner
✨
Troy Wilson shares insights on precision cancer drugs.
Troy Wilson
✨
Sri Kosuri explains small molecules for protein misfolding.
Sri Kosuri
✨
Becky Pferdehirt discusses reimagining science for the AI era.
Becky Pferdehirt
✨
Jeremy Levin discusses his book "Biotech in the Balance."
✨
Richard Pops reflects on his 35-year biotech career.
Richard Pops Reflects
✨
Marty Burke discusses automated small molecule synthesis.
Martin Burke
✨
Abbas Kazimi talks about computation and culture in drug discovery.
✨
Viswa Colluru discusses drug discovery inspired by nature.
Viswa Colluru
✨
Otello Stampacchia addresses Europe's biotech investment crisis.
Otello Stampacchia
✨
Ken Song discusses T-cell engagers for autoimmune diseases.
Ken Song
✨
Ansu Satpathy discusses cancer and autoimmune drug discovery.
Ansu Satpathy
✨
Ron Renaud discusses GLP-1 medicines for weight loss.
Ron Renaud
✨
Kate Haviland discusses Blueprint Medicines' transition to precision immunology.
Kate Haviland